IMDRF terminologies for categorized Adverse Event ...
both pre and post market as described in section 5. Notably, the precise criteria for reporting adverse events are defined by each regulatory authority and are not subject to this guidance document. Reference is made to the relevant guidance documents of each jurisdiction and the GHTF document on Post Market Surveillance:
Tags:
Surveillance, Market, Authority, Market surveillance
Information
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
Advertisement
Documents from same domain
GHTF SG2 Medical Devices: Post Market …
www.imdrf.orgFebruary 2009 3 / 13 Medical Devices: Post Market Surveillance: National Competent Authority Report Exchange Criteria and Report Form: GHTF/SG2/N79R11:2009
Devices, Report, Medical, Surveillance, National, Market, Authority, Medical device, Competent, Market surveillance, National competent authority report
GHTF SG1 - Summary Technical Documentation …
www.imdrf.orgSummary Technical Documentation for Demonstrating Conformity to the Essential Principles of Safety and Performance of IVD Medical Devices (STED)
GHTF SG1 Safety and Performance of Medical …
www.imdrf.orgEssential Principles of Safety and Performance of Medical Devices Study Group 1 Final Document GHTF/SG1/N68:2012 November 2nd, 2012 Page 2 of …
Performance, Devices, Medical, Safety, Safety and performance of medical, Safety and performance of medical devices
Nonconformity Grading System for Regulatory …
www.imdrf.orgNonconformity Grading System for Regulatory Purposes and Information Exchange Study Group 3 Final Document GHTF/SG3/N19:2012 November 2nd, 2012 Page 3 of 16 Preface
Information, System, Regulatory, Purpose, Exchange, Grading, Nonconformity, Nonconformity grading system for regulatory, Nonconformity grading system for regulatory purposes and information exchange
Software as a Medical Device (SaMD): Key definitions
www.imdrf.orgIMDRF/SaMD WG/N10FINAL:2013 _____ 5.0 Key Definitions 5.1 Software as a Medical Device
GHTF SG1 - Label and Instructions for Use for …
www.imdrf.orgLabel and Instructions for Use for Medical Devices Study Group 1 Final Document GHTF/SG1/N70:2011 September 16 th, 2011 Page 4 of 17 1.0
Devices, Label, Document, Medical, Instructions, Label and instructions for use for, Label and instructions for use for medical devices
PROPOSED REVISED DOCUMENT - IMDRF
www.imdrf.orgSG1(PD)/N011R20 PROPOSED REVISED DOCUMENT Global Harmonization Task Force Title: Summary Technical Documentation for Demonstrating Conformity to the Essential Principles of Safety and Performance of Medical Devices
Proposed, Document, Global, Technical, Documentation, Revised, Summary, Tasks, Force, Harmonization, Proposed revised document, Proposed revised document global harmonization task force, Summary technical documentation
GHTF SG4 - Guidelines for Regulatory Auditing of …
www.imdrf.orgGuidelines for Regulatory Auditing of Quality Management Systems of Medical Device Manufacturers Part 5: Audits of manufacturer control of suppliers
Guidelines, Regulatory, Auditing, Sg4 guidelines for regulatory auditing of, Guidelines for regulatory auditing of
'Software as a Medical Device': Possible Framework …
www.imdrf.orgThe objective of this document is to introduce a foundational approach, harmonized vocabulary and general and specific considerations for manufacturers, regulators, and users alike to address
GHTF SG5 Key Definitions and Concepts - IMDRF
www.imdrf.orgClinical Evidence – Key Definitions and Concepts Study Group 5 Proposed Document SG5(PD)N1R7 April 26, 2006 Page 3 of 8 Preface The document herein was produced by the Global Harmonization Task Force, a voluntary group
Definition, Global, Clinical, Concept, Tasks, Force, Harmonization, Ghtf, Global harmonization task force, Ghtf sg5 key definitions and concepts, Imdrf, Key definitions and concepts
Related documents
EUROPEAN COMMISSION DG Health and Consumers (SANCO ...
meddev.infomarket surveillance; ... The term "post-marketing surveillance" as referred to in Annexes 2, 4, 5 in AIMD has the ... National Competent Authorities outside Europe who are involved in the GHTF National Competent Authority Report (NCAR) exchange programme. These guidelines are relevant to INCIDENTs occurring within the Member States of the ...
Report, Surveillance, National, Market, Authority, Competent, Market surveillance, National competent authority report, National competent
Information on the Member States requirement for the ...
www.ema.europa.euthe Austrian competent authority has the option to require the nomination ... marketing surveillance studies on the market, the volume of sales or ... pharmacovigilance contact person at national level shall: • report to the QPPV (reporting in this context relat es to :
Report, Surveillance, National, Market, Authority, Competent, Competent authority
Vigilance Reporting - BSI Group
www.bsigroup.comMust Report - Trends . If a significant increase or trend of events or incidents that are usually excluded from individual reporting . The manufacturer should have suitable systems in place for proactive scrutiny of trends in complaints and incidents occurring with their devices - MedDev 2.12.1 . Report to National Competent Authority
Report, Reporting, National, Authority, Competent, Vigilance, Vigilance reporting, National competent authority
THE NATIONAL INTERNAL REVENUE CODE OF THE …
www.seatca.org(E) Authority of the Commissioner to Prescribe Real Property Values. - The Commissioner is hereby authorized to divide the Philippines into different zones or areas and shall, upon consultation with competent appraisers both from the private and public sectors, determine the fair market value of real properties located in each zone or area.
Clinical Evaluation Reports from the medical writer’s ...
journal.emwa.orgpost-market surveillance (PMS) information. Summary Although it is the first section to be read, the summary is the last to be written. The summary should give a succinct overview of the clinical condition and state of the art; brief details of the subject device and its indication; conclusions of the evaluation pre-clinical studies, pre-market
Evaluation, Surveillance, Clinical, Market, Market surveillance, Clinical evaluation